• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Scrotal Paget's Disease Associated With Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Apocrine Carcinoma With Complete Response to Paclitaxel, Trastuzumab, and Pertuzumab.

作者信息

Nowicka-Matus Kinga, Salkus Giedrius, Sønderkær Mads, Søkilde Pedersen Inge, Ernst Anja, Kubik Magdalena, Takacs-Szabo Zsuzsanna, Ladekarl Morten

机构信息

Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.

Department of Pathology, Aalborg University Hospital, Aalborg, Denmark.

出版信息

JCO Precis Oncol. 2023 Aug;7:e2300173. doi: 10.1200/PO.23.00173.

DOI:10.1200/PO.23.00173
PMID:37595182
Abstract
摘要

相似文献

1
Scrotal Paget's Disease Associated With Human Epidermal Growth Factor Receptor 2-Overexpressing Metastatic Apocrine Carcinoma With Complete Response to Paclitaxel, Trastuzumab, and Pertuzumab.阴囊佩吉特病伴人表皮生长因子受体2过表达转移性大汗腺癌，对紫杉醇、曲妥珠单抗和帕妥珠单抗完全缓解
JCO Precis Oncol. 2023 Aug;7:e2300173. doi: 10.1200/PO.23.00173.
2
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study.曲妥珠单抗和帕妥珠单抗联合每周一次紫杉醇治疗HER2过表达转移性乳腺癌患者：一项II期研究的总生存和更新的无进展生存结果
Breast Cancer Res Treat. 2016 Jul;158(1):91-97. doi: 10.1007/s10549-016-3851-7. Epub 2016 Jun 15.
3
Complete but transient clinical remission of vulvar Paget's disease with paclitaxel and trastuzumab.紫杉醇联合曲妥珠单抗治疗外阴佩吉特病实现完全但短暂的临床缓解
Ann Dermatol Venereol. 2021 Mar;148(1):47-48. doi: 10.1016/j.annder.2020.08.048. Epub 2021 Jan 6.
4
Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5-Year Follow-up.Ⅱ期研究：曲妥珠单抗联合帕妥珠单抗联合每周紫杉醇治疗人表皮生长因子受体 2 过表达转移性乳腺癌患者：5 年随访。
Oncologist. 2019 Aug;24(8):e646-e652. doi: 10.1634/theoncologist.2018-0512. Epub 2019 Jan 2.
5
Experiences of trastuzumab plus paclitaxel combination therapy in metastatic human epidermal growth factor receptor 2-positive extramammary Paget's disease: Four cases and a review.曲妥珠单抗联合紫杉醇治疗转移性人表皮生长因子受体2阳性乳腺外佩吉特病的经验：4例病例及文献复习
J Dermatol. 2020 Nov;47(11):1276-1279. doi: 10.1111/1346-8138.15515. Epub 2020 Jul 24.
6
Predictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel.曲妥珠单抗和帕妥珠单抗联合艾立布林或白蛋白紫杉醇治疗人表皮生长因子受体 2 阳性晚期乳腺癌患者中绝对淋巴细胞计数对无进展生存期的预测影响。
BMC Cancer. 2018 Oct 16;18(1):982. doi: 10.1186/s12885-018-4888-2.
7
A Case of Metastatic Extramammary Paget's Disease Responding to Trastuzumab plus Paclitaxel Combination Therapy.一例对曲妥珠单抗联合紫杉醇治疗有效的转移性乳腺外佩吉特病病例
Case Rep Dermatol. 2011 Sep;3(3):223-7. doi: 10.1159/000333002. Epub 2011 Oct 11.
8
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.HER2阳性、激素受体阴性早期乳腺癌的降阶梯新辅助帕妥珠单抗联合曲妥珠单抗治疗（联合或不联合每周一次紫杉醇）（WSG-ADAPT-HER2+/HR-）：一项多中心、开放标签、随机2期试验的生存结果
Lancet Oncol. 2022 May;23(5):625-635. doi: 10.1016/S1470-2045(22)00159-0. Epub 2022 Apr 8.
9
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.人表皮生长因子受体-2（HER2）是外阴派杰氏病的潜在治疗靶点。
Int J Gynecol Cancer. 2020 Nov;30(11):1672-1677. doi: 10.1136/ijgc-2020-001771. Epub 2020 Sep 30.
10
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.每周一次给予紫杉醇联合曲妥珠单抗和帕妥珠单抗治疗人表皮生长因子受体2阳性转移性乳腺癌患者的II期研究。
J Clin Oncol. 2015 Feb 10;33(5):442-7. doi: 10.1200/JCO.2014.57.1745. Epub 2014 Dec 29.

引用本文的文献

1
Challenges in treating coexisting scrotal apocrine carcinoma and gastric cancer: insights from an elderly patient: a case report and literature review.同时患有阴囊大汗腺癌和胃癌的治疗挑战：老年患者的启示：病例报告和文献复习。
BMC Geriatr. 2024 Oct 15;24(1):836. doi: 10.1186/s12877-024-05428-w.
2
Exome sequencing reveals biallelic inactivation of in cutaneous apocrine carcinoma: A case report and review of the literature.外显子组测序揭示皮肤大汗腺癌中[具体基因]的双等位基因失活：一例病例报告及文献复习
JAAD Case Rep. 2024 Apr 25;49:47-50. doi: 10.1016/j.jdcr.2024.04.025. eCollection 2024 Jul.